Sernova Biotherapeutics Inc (FRA:PSH0)
0.1180
+0.0030 (2.61%)
At close: Sep 9, 2025
Sernova Biotherapeutics Market Cap
Sernova Biotherapeutics has a market cap or net worth of €38.50 million as of September 10, 2025. Its market cap has decreased by -12.83% in one year.
Market Cap
38.50M
Enterprise Value
40.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.12
Market Cap Chart
Since June 29, 2000, Sernova Biotherapeutics's market cap has increased from 12.10M to 38.50M, an increase of 218.18%. That is a compound annual growth rate of 4.70%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 8, 2025 | 36.41M | -26.61% |
Dec 31, 2024 | 49.62M | -67.75% |
Dec 29, 2023 | 153.86M | -3.89% |
Dec 30, 2022 | 160.10M | -51.52% |
Dec 31, 2021 | 330.23M | 266.42% |
Dec 31, 2020 | 90.12M | 293.80% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 268.21B |
Siemens Aktiengesellschaft | 177.41B |
Deutsche Telekom AG | 148.75B |
Allianz SE | 134.60B |
Rheinmetall AG | 81.51B |
Siemens Energy AG | 71.89B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.57B |
Deutsche Bank Aktiengesellschaft | 58.53B |